Effect of bevacizumab on the expression of fibrosis-related inflammatory mediators in ARPE-19 cells
Author(s) -
San-jun Chu,
Zhaohua Zhang,
Min Wang,
Haifeng Xu
Publication year - 2017
Publication title -
international journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 29
eISSN - 2227-4898
pISSN - 2222-3959
DOI - 10.18240/ijo.2017.03.07
Subject(s) - medicine , bevacizumab , inflammation , fibrosis , bioinformatics , ophthalmology , pharmacology , cancer research , chemotherapy , biology
To investigate the effect of anti-vascular epithelial growth factor (VEGF) agents on the expression of fibrosis-related inflammatory mediators under normoxic and hypoxic conditions, and to further clarify the mechanism underlying fibrosis after anti-VEGF therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom